inositol has been researched along with Preterm Birth in 12 studies
Inositol: An isomer of glucose that has traditionally been considered to be a B vitamin although it has an uncertain status as a vitamin and a deficiency syndrome has not been identified in man. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1379) Inositol phospholipids are important in signal transduction.
inositol : Any cyclohexane-1,2,3,4,5,6-hexol.
1D-chiro-inositol : Belonging to the inositol family of compounds, D-chiro-inositol (DCI) is an isomer of glucose. It is an important secondary messenger in insulin signal transduction.
muco-inositol : An inositol that is cyclohexane-1,2,3,4,5,6-hexol having a (1R,2R,3r,4R,5S,6r)-configuration.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Inclusion criteria were randomized controlled trials (RCTs) that enrolled overweight and obese pregnant women and used myo-inositol supplementation." | 9.41 | The Efficacy and Safety of Myo-inositol Supplementation for the Prevention of Gestational Diabetes Mellitus in Overweight and Obese Pregnant Women: A Systematic Review and Meta-Analysis. ( Corpuz, H; Factor, PA, 2023) |
| "Evidence from seven studies shows that antenatal dietary supplementation with myo-inositol during pregnancy may reduce the incidence of gestational diabetes, hypertensive disorders of pregnancy and preterm birth." | 5.41 | Antenatal dietary supplementation with myo-inositol for preventing gestational diabetes. ( Alsweiler, J; Crawford, TJ; Crowther, CA; Lin, L; Motuhifonua, SK, 2023) |
| " Inclusion criteria were randomized controlled trials (RCTs) that enrolled overweight and obese pregnant women and used myo-inositol supplementation." | 5.41 | The Efficacy and Safety of Myo-inositol Supplementation for the Prevention of Gestational Diabetes Mellitus in Overweight and Obese Pregnant Women: A Systematic Review and Meta-Analysis. ( Corpuz, H; Factor, PA, 2023) |
| "Myo-inositol treatment in early pregnancy is associated with a reduction in the rate of gestational diabetes mellitus and in the risk of preterm birth and macrosomia in women who are at risk for gestational diabetes mellitus." | 3.88 | Clinical and metabolic outcomes in pregnant women at risk for gestational diabetes mellitus supplemented with myo-inositol: a secondary analysis from 3 RCTs. ( Alibrandi, A; Corrado, F; D'Anna, R; Di Benedetto, A; Facchinetti, F; Pintaudi, B; Santamaria, A, 2018) |
| "Although gestational diabetes mellitus (GDM) has several short- and long-term adverse effects on the mother and the offspring, no medicine is generally prescribed to prevent GDM." | 3.01 | Myoinositols Prevent Gestational Diabetes Mellitus and Related Complications: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. ( Ács, N; Greff, D; Hegyi, P; Horváth, EM; Nyirády, P; Park, S; Szinte, J; Váncsa, S; Váradi, A; Várbíró, S, 2023) |
| "A total of 26 prematurely born intrauterine growth restriction infants (birthweight <10th centile for gestational age), 22 prematurely born but adequate for gestational age controls, and 26 term adequate-for-gestational-age infants underwent brain magnetic resonance imaging and magnetic resonance spectroscopy at 1 year of age during natural sleep, on a 3 Tesla scanner." | 1.46 | Brain metabolite alterations in infants born preterm with intrauterine growth restriction: association with structural changes and neurodevelopmental outcome. ( Bargalló, N; Cruz-Lemini, M; Eixarch, E; Gratacós, E; Muñoz-Moreno, E; Sanz-Cortés, M; Simões, RV, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (41.67) | 24.3611 |
| 2020's | 7 (58.33) | 2.80 |
| Authors | Studies |
|---|---|
| Sharma, N | 1 |
| Watkins, OC | 1 |
| Chu, AHY | 1 |
| Cutfield, W | 2 |
| Godfrey, KM | 2 |
| Yong, HEJ | 1 |
| Chan, SY | 2 |
| Liu, Q | 1 |
| Liu, Z | 1 |
| Guarnotta, V | 1 |
| Cuva, G | 1 |
| Imbergamo, MP | 1 |
| Giordano, C | 1 |
| Motuhifonua, SK | 1 |
| Lin, L | 1 |
| Alsweiler, J | 1 |
| Crawford, TJ | 1 |
| Crowther, CA | 1 |
| Greff, D | 1 |
| Váncsa, S | 1 |
| Váradi, A | 1 |
| Szinte, J | 1 |
| Park, S | 1 |
| Hegyi, P | 1 |
| Nyirády, P | 1 |
| Ács, N | 1 |
| Horváth, EM | 1 |
| Várbíró, S | 1 |
| Factor, PA | 1 |
| Corpuz, H | 1 |
| Barton, SJ | 1 |
| El-Heis, S | 1 |
| Kenealy, T | 1 |
| Nield, H | 1 |
| Baker, PN | 1 |
| Chong, YS | 1 |
| Zhang, H | 1 |
| Lv, Y | 1 |
| Li, Z | 1 |
| Sun, L | 1 |
| Guo, W | 1 |
| Santamaria, A | 1 |
| Alibrandi, A | 1 |
| Di Benedetto, A | 1 |
| Pintaudi, B | 1 |
| Corrado, F | 1 |
| Facchinetti, F | 1 |
| D'Anna, R | 1 |
| Vitagliano, A | 1 |
| Saccone, G | 1 |
| Cosmi, E | 1 |
| Visentin, S | 1 |
| Dessole, F | 1 |
| Ambrosini, G | 1 |
| Berghella, V | 1 |
| Moles, L | 1 |
| Manzano, S | 1 |
| Fernández, L | 1 |
| Montilla, A | 1 |
| Corzo, N | 1 |
| Ares, S | 1 |
| Rodríguez, JM | 1 |
| Espinosa-Martos, I | 1 |
| Simões, RV | 1 |
| Muñoz-Moreno, E | 1 |
| Cruz-Lemini, M | 1 |
| Eixarch, E | 1 |
| Bargalló, N | 1 |
| Sanz-Cortés, M | 1 |
| Gratacós, E | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Myoinositol on Serum Asprosin Levels in Pregnant Women[NCT05943158] | 40 participants (Actual) | Interventional | 2021-06-01 | Completed | |||
| Nutritional Intervention Preconception and During Pregnancy to Maintain Healthy Glucose Metabolism and Offspring Health - Child Health and Well-being Follow Up Study[NCT05934422] | 510 participants (Anticipated) | Interventional | 2023-06-16 | Enrolling by invitation | |||
| "Nutritional Intervention Preconception and During Pregnancy to Maintain Healthy Glucose Metabolism and Offspring Health (NiPPeR)"[NCT02509988] | 1,729 participants (Actual) | Interventional | 2015-07-31 | Completed | |||
| Myoinositol Supplementation, Insulin Resistance and Fetal Sonographic Parameters in Gestational Diabetes, Diet Treated: a Prospective, Randomized, Placebo-controlled Study[NCT03763669] | 120 participants (Actual) | Interventional | 2018-11-14 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
7 reviews available for inositol and Preterm Birth
| Article | Year |
|---|---|
Topics: Diabetes, Gestational; Female; Fetal Membranes, Premature Rupture; Humans; Infant, Newborn; Inositol | 2023 |
The efficacy of myo-inositol supplementation to reduce the incidence of gestational diabetes: a meta-analysis.
Topics: Diabetes, Gestational; Dietary Supplements; Female; Glucose; Humans; Incidence; Infant, Newborn; Ino | 2022 |
Antenatal dietary supplementation with myo-inositol for preventing gestational diabetes.
Topics: Adult; Diabetes Mellitus, Type 2; Diabetes, Gestational; Dietary Supplements; Female; Humans; Hypert | 2023 |
Myoinositols Prevent Gestational Diabetes Mellitus and Related Complications: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Topics: Diabetes, Gestational; Female; Humans; Hypertension, Pregnancy-Induced; Hypoglycemia; Infant, Newbor | 2023 |
The Efficacy and Safety of Myo-inositol Supplementation for the Prevention of Gestational Diabetes Mellitus in Overweight and Obese Pregnant Women: A Systematic Review and Meta-Analysis.
Topics: Diabetes, Gestational; Dietary Supplements; Female; Humans; Hypertension, Pregnancy-Induced; Infant, | 2023 |
The efficacy of myo-inositol supplementation to prevent gestational diabetes onset: a meta-analysis of randomized controlled trials.
Topics: Adult; Diabetes, Gestational; Female; Gestational Age; Humans; Inositol; Pregnancy; Premature Birth; | 2019 |
Inositol for the prevention of gestational diabetes: a systematic review and meta-analysis of randomized controlled trials.
Topics: Adult; Blood Glucose; Diabetes, Gestational; Female; Humans; Infant, Newborn; Inositol; Insulin; Odd | 2019 |
1 trial available for inositol and Preterm Birth
4 other studies available for inositol and Preterm Birth
| Article | Year |
|---|---|
Myoinositol supplementation in the treatment of gestational diabetes mellitus: effects on glycaemic control and maternal-foetal outcomes.
Topics: Blood Glucose; Diabetes, Gestational; Dietary Supplements; Female; Glycemic Control; Humans; Infant, | 2022 |
Clinical and metabolic outcomes in pregnant women at risk for gestational diabetes mellitus supplemented with myo-inositol: a secondary analysis from 3 RCTs.
Topics: Adult; Diabetes Mellitus, Type 2; Diabetes, Gestational; Dietary Supplements; Female; Fetal Growth R | 2018 |
Bacteriological, biochemical, and immunological properties of colostrum and mature milk from mothers of extremely preterm infants.
Topics: Adult; Bacterial Load; Chemokines; Colostrum; Cytokines; Female; Glucose; Gram-Negative Bacteria; Gr | 2015 |
Brain metabolite alterations in infants born preterm with intrauterine growth restriction: association with structural changes and neurodevelopmental outcome.
Topics: Adaptation, Psychological; Anisotropy; Aspartic Acid; Brain; Child, Preschool; Choline; Cognition; C | 2017 |